MARKET

MANE

MANE

VERADERMICS INC
NYSE
129.66
-5.63
-4.16%
After Hours: 128.00 -1.66 -1.28% 19:57 11/13 EST
OPEN
134.06
PREV CLOSE
135.29
HIGH
136.97
LOW
128.24
VOLUME
938.03K
TURNOVER
--
52 WEEK HIGH
156.63
52 WEEK LOW
32.00
MARKET CAP
5.47B
P/E (TTM)
-40.4467
1D
5D
1M
3M
1Y
5Y
1D
Veradermics, Incorporated (MANE) Receives a Buy from Leerink Partners
TipRanks · 1d ago
Veradermics to Present at the Jefferies Global Healthcare Conference in London
Barchart · 2d ago
Veradermics Price Target Raised to $175.00/Share From $160.00 by Citigroup
Dow Jones · 4d ago
Veradermics Is Maintained at Buy by Citigroup
Dow Jones · 4d ago
Citigroup Maintains Buy on Veradermics, Raises Price Target to $175
Benzinga · 4d ago
Veradermics price target raised to $175 from $160 at Citi
TipRanks · 4d ago
Veradermics: Q3 Earnings Snapshot
Barchart · 4d ago
Veradermics reports Q3 net loss ($21M) vs. ($20.1M) last year
TipRanks · 4d ago
More
About MANE
Veradermics, Incorporated is a late clinical-stage biopharmaceutical company. The Company is focused on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. Its initial focus is developing better treatments for pattern hair loss (PHL). The Company is developing VDPHL01 as an oral, non-hormonal treatment for men and women with PHL to reduce the barriers to wide adoption of chronic hair loss therapy and potentially transform PHL treatment. VDPHL01 is an oral, ER formulation of minoxidil, a proven hair growth agent, designed to maximize minoxidil’s impact on hair restoration while minimizing the risk of cardiac activity. The Company is conducting a Phase II clinical trial evaluating VDPHL01 in male and female patients with mild-to-moderate PHL.

Webull offers Veradermics Inc stock information, including NYSE: MANE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MANE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MANE stock methods without spending real money on the virtual paper trading platform.